BIOMAT Database Logo BIOMAT Database Logo

[Evaluation of factor VIII deficient plasma used as the control in quantitative analysis of factor VIII]. 1971

K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe

UI MeSH Term Description Entries
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Evaluation of factor VIII deficient plasmas.
September 1993, Thrombosis and haemostasis,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
December 2001, Thrombosis and haemostasis,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Kininogen in factor VIII-deficient plasma (haemophilia A).
November 1981, Thrombosis research,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Preparation of factor VIII-deficient plasma by immunoadsorption.
January 1979, Vox sanguinis,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Dilution of haemophilic plasma used as a reagent in the determination of anti-haemophilic factor A (factor VIII).
January 1974, Haemostasis,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Heterogeneous coagulant potential of emicizumab in neonatal factor VIII-deficient plasma.
July 2022, Pediatric blood & cancer,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Mimicking Factor VIII to Manage the Factor VIII-Deficient State.
August 2018, The New England journal of medicine,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Plasma factor VIII synthesis and control as revealed by canine organ transplantation.
May 1971, The American journal of physiology,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci.
August 2003, Journal of thrombosis and haemostasis : JTH,
K Okuma, and S Yoshimura, and T Kubota, and Y Inaoka, and H Kawagoe
Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
March 2008, Anesthesia and analgesia,
Copied contents to your clipboard!